Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (21052)	5/18/1998 1:45:00 PM
From: dwc	Respond to of 32384

Tony: "Its Soooooooooooo predicable :-)" What is this...the wit and wisdom of Daffy Duck? Hope you don't think me dispicable.

To: tonyt who wrote (21052)	5/18/1998 1:46:00 PM
From: bob zagorin	Read Replies (1) \| Respond to of 32384

imo, its tonyt and mudcate that are very predictable. LGND did get mentioned in S&P Personmal Wealth coverage today. "FDA Panel Recommends Approval of Genzyme Corp.'s Thyrogen" personalwealth.com Genzyme Corp. (Nasdaq: GENZ) said an FDA advisory committee recommended approval of its Thyrogen recombinant human thyroid stimulating hormone for use in the evaluation of patients being tested for thyroid cancer metastases. Other stocks featured in this morning's MarketMovers include Microsoft (Nasdaq: MSFT), Viacom Inc. (ASE: VIA.B), Lowe's Cos. NYSE: LOW), Numerex Corp. (Nasdaq: NMRX), Tadiran Limited (NYSE:TAD), Limited Inc. (NYSE: LTD), Ligand Pharmaceuticals (Nasdaq: LGND), Data Broadcasting (Nasdaq: DBCC), and Printronix Inc. (NYSE: PTNX